| |
All n = 210
|
GG n = 146
|
GC/CC n = 64
|
p value
|
|---|
|
SOFA
|
7.6 ± 4.5
|
7.9 ± 4.5
|
6.8 ± 4.2
|
0.0005
|
|
SOFA-Respiratory score
|
2.1 ± 1.1
|
2.1 ± 1.1
|
2.0 ± 1.1
|
0.1950
|
|
SOFA-Cardiovascular score
|
1.6 ± 1.5
|
1.7 ± 1.5
|
1.4 ± 1.4
|
0.1296
|
|
SOFA-Central nervous system score
|
2.0 ± 1.5
|
2.1 ± 1.5
|
1.9 ± 1.4
|
0.0802
|
|
SOFA-Renal score
|
0.9 ± 1.4
|
1.0 ± 1.4
|
0.7 ± 1.2
|
0.0005
|
|
SOFA-Coagulation score
|
0.3 ± 0.8
|
0.4 ± 0.8
|
0.3 ± 0.7
|
0.0245
|
|
SOFA-Hepatic score
|
0.3 ± 0.7
|
0.4 ± 0.8
|
0.2 ± 0.5
|
<0.0001
|
|
Mortality analysis, %:
| | | | |
|
Death at day 28
|
18
|
18
|
17
|
1.0000
|
|
Death at day 90
|
30
|
30
|
28
|
0.8698
|
|
Length of stay in ICU (days)
|
18 ± 16
|
18 ± 17
|
20 ± 14
|
0.0720
|
|
Organ support*, %
| | | | |
|
Mechanical ventilation
| |
75
|
74
|
0.6286
|
|
Use of vasopressor
| |
38
|
37
|
0.8426
|
|
Renal replacement therapy
| |
14
|
9
|
0.4486
|
- The data are presented as the mean ± SD or percentages.
-
*Based on the total number of observations in follow-up days.
